CN Bio’s aim is to transform the way human-relevant pre-clinical data is generated to improve drug discovery efficiency. Our PhysioMimix™ OOC range of microphysiological systems & services enable researchers to predict human liver responses to acute & chronic drug exposure in the presence or absence of disease using single- or multi-organ liver-on-a-chip models. By recreating human physiology in vitro, PhysioMimix OOC provides high-content, predictive data that translates between lab and clinic.